Prevail InfoWorks’ Post

🌟 Exciting News Alert 🌟 🔬 Did you catch the recent BBC article about an innovative alternative to uncomfortable smear tests? If not, you're in for a treat! As featured on BBC, we are thrilled to introduce our groundbreaking solution that promises to revolutionize the experience of cervical cancer screening. No more discomfort, no more anxiety — just a simple and hassle-free alternative that prioritizes your comfort. Our team has been tirelessly working to create a game-changing approach that ensures every woman feels at ease during this crucial health check. With this innovation, we aim to encourage more women to prioritize their cervical health without the dread of a traditional smear test. Curious to learn more about this groundbreaking alternative? Check out the full article and let's start a conversation about the future of cervical cancer screening! #CervicalHealth #Innovation #WomenEmpowerment https://ift.tt/AGoEpyP

We're delighted to highlight Teal Health's pioneering work in expanding cervical cancer screening access! A self-collection HPV testing device is revolutionizing cancer detection with SELF-CERV at Teal Health. The convenient screening option aims to reach the 25% of women who aren't up to date on lifesaving tests. As explains: "At-home screening options will provide a great alternative to the traditional speculum exam and will increase access and address barriers, specifically the need for a more convenient and comfortable experience." A total of 15 top health centres, including multiple Planned Parenthood Research Network locations, have signed up to participate in the SELF-CERV initiative to evaluate effectiveness compared with in-clinic testing. This measure could have a HUGE impact on screening adherence if self-collection detects high-risk HPV at the same rates as screenings. Brava, Teal Health, and Kara Egan on this promising stride toward democratizing healthcare for women! 👏 👥 Follow us on LinkedIn for the latest in Femtech news. 🌐 Visit our website at www.femovate.com to explore innovative solutions in women's health! #femtech #medtech #digitalhealth #uxdesign #innovation #womenshealth #healthtech #femovate #femtechgrant

Early detection of breast cancer is a critical step in ensuring better outcomes and survival rates, and this begins with education and awareness. Being well-informed about the signs and symptoms of breast cancer is crucial for every woman. Understanding one's family history is particularly important, as it can provide insights into potential hereditary risks. It is essential to be vigilant about any changes in the texture of the skin, the appearance of lumps in the breast or underarm area, and other unusual symptoms. These signs should never be ignored, as early identification of these symptoms can lead to early diagnosis and treatment, significantly improving the chances of successful outcomes. In the fight against breast cancer, promoting early detection and raising awareness are fundamental. The advancement of new technologies has made it easier to diagnose and monitor breast cancer in its early stages. These technologies are continually evolving, offering more effective and less invasive options for detection. It's crucial for communities to share information about these advancements and the importance of regular check-ups. By encouraging open conversations and supporting each other in staying informed and proactive about breast health, we can collectively contribute to the health and well-being of all women. Early detection not only saves lives but also empowers women to take charge of their health. #medtech #innovation #healthinnovation #medicalinnovation #earlydetection #breastcancer #breastcancerawareness

Cervical Screening Awareness Week, celebrated annually in June, aims to educate women about the significance of cervical screening in preventing cervical cancer by encouraging them to attend their screening appointments. As per the 𝑈𝐾 𝑔𝑜𝑣𝑒𝑟𝑛𝑚𝑒𝑛𝑡, regular cervical screening can prevent up to 𝟕𝟓% of cervical cancer cases, potentially saving around 𝟓,𝟎𝟎𝟎 lives annually. By early detection of abnormal cells in the cervix, cervical screening significantly reduces the incidence of cervical cancer and improves survival rates. In this regard, immunohistochemistry (IHC) is a key technique used in cervical screening to enhance the accuracy of diagnosis. It involves the use of antibodies to detect specific antigens in cells, allowing for precise identification of cancerous cells. Thus, the integration of immunohistochemistry into cervical screening protocols increases the specificity of cancer detection, thereby aiding in the formulation of personalized treatment plans. The success of IHC in cervical screening is prompting healthcare providers to explore its potential in screening for other cancers and diseases, thereby stimulating market growth for immunohistochemistry. Accordingly, Triton’s research analysis predicts that the Global Immunohistochemistry Market is set to rise at a CAGR of 𝟕.𝟏𝟏% during the forecast period 2019-2027. As cervical screening programs adopt IHC techniques to improve diagnostic accuracy, the demand for IHC reagents, antibodies, and detection kits rises. On this Cervical Screening Awareness Week, it is essential to recognize the advancements in screening technologies, such as IHC, that are making a significant impact on women’s health. Get a detailed analysis of the current trends within the immunohistochemistry market or request a free sample here: https://lnkd.in/dA6PvN4x . . . Abbott abcam Agilent Technologies BioGenex #cervicalscreeningawarenessweek #cervicalscreening #immunohistochemistry #healthcare #biotechnology #cervicalcancer #marketgrowth #tritonmarketresearch

This BMJ article also highlights the >2% annual rise in the incidence of #melanoma during the last 25 years. #Teledermatology pathways are one way to cope with increased referrals with possible skin cancer in private & public sectors and, our Faster Diagnosis Standard of 97% for all skin cancer types compares very favourably with current NHS waiting times for melanoma alone. Teledermatology pathways can be scaled by use of AI models for automated lesion classification and, our own AI model, funded by Innovate UK and developed with the University of Essex, has confirmed the importance of the clinical data as well as the images in developing a highly accurate model that we hope to deploy by the end of 2024. Check4Cancer Ltd UK Research and Innovation https://lnkd.in/eZWKhE23

Frequently Asked Questions HOW DO I KNOW IF MY OVARIAN OR OTHER CANCER WAS CAUSED BY BABY POWDER? The tissue samples and pathology reports that were used to diagnose the cancer and determine the best method of treatment can be examined now to determine if your tissues contain baby powder fibers. By reviewing your medical records and sending your pathology reports to a baby powder cancer expert, they can determine whether baby powder may have caused your cancer. WHO IS AT RISK OF OVARIAN CANCER FROM BABY POWDER PRODUCTS? Any woman who has used baby powder products on a daily or weekly basis for an extended amount of time. African American and Latina women were targeted for the sale of this powder. HOW IS BABY POWDER DANGEROUS? When baby powder products are applied to the genital region baby powder particles can travel through the female reproductive system to the ovaries and remain for many years. This creates an environment conducive to the growth of cancer cells. LEARN MORE: https://lnkd.in/eFF_qiKJ

Early detection is key in the fight against breast cancer which can be conquered by harnessing technological advancements. However, access to quality healthcare remains a challenge for many in India. This insightful article by Hariharan NS published by SheThePeople.TV sheds light on the need for a multi-pronged approach to tackle this critical issue. It touches upon: - The importance of awareness campaigns and education. - Technological advancements aiding early diagnosis. - Addressing the gap in access to quality healthcare Let's work together to create a future where breast cancer is a battle won, not a war fought alone. Read the full article from https://t.ly/-iIPB Pranav Patil Sanket Kathe Singaravelu V.B Chandra Sekhar Carla Omoto Kunmun . #siemenshealthineers #breastcancerawareness #india

LEARN MORE: https://lnkd.in/eFF_qiKJ Frequently Asked Questions HOW DO I KNOW IF MY OVARIAN OR OTHER CANCER WAS CAUSED BY BABY POWDER? The tissue samples and pathology reports that were used to diagnose the cancer and determine the best method of treatment can be examined now to determine if your tissues contain baby powder fibers. By reviewing your medical records and sending your pathology reports to a baby powder cancer expert, they can determine whether baby powder may have caused your cancer. WHO IS AT RISK OF OVARIAN CANCER FROM BABY POWDER PRODUCTS? Any woman who has used baby powder products on a daily or weekly basis for an extended amount of time. African American and Latina women were targeted for the sale of this powder. HOW IS BABY POWDER DANGEROUS? When baby powder products are applied to the genital region baby powder particles can travel through the female reproductive system to the ovaries and remain for many years. This creates an environment conducive to the growth of cancer cells.

Knowledge about cervical cancer in young Portuguese women: a cross-sectional study Health literacy is crucial to adherence to medical interventions in therapeutics, prevention, and diagnosis. The basis for literacy is knowledge. To accomplish the goals for the elimination of cervical cancer, one of the most prevalent and preventable cancers, we must understand the determinants of non-adherence and address them specifically to ensure patients’ active participation.